Clinical trials will be conducted at Centers of Excellence at four historically Black medical schools
The Beacon of Hope program aims to strengthen clinical trial capabilities, improve the quality and inclusivity of clinical trials and help rebuild trust in the healthcare system within Black communities
Initiative is part of Sanofi's broader commitment to increase clinical trial diversity throughout the entire ecosystem – from study design and eligibility criteria to site selection, recruitment materials, and engagement with local communities
First and only investigational Phase 3 trial to show positive results in these young children; results follow recent approval of Dupixent in people with eosinophilic esophagitis aged 12 years and older who weigh at least 40 kilograms
- Investigational once-weekly efanesoctocog alfa prophylaxis met the primary efficacy endpoint providing clinically meaningful bleed protection for people with severe hemophilia A